Compare TLRY & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLRY | CRON |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 976.4M |
| IPO Year | 2018 | N/A |
| Metric | TLRY | CRON |
|---|---|---|
| Price | $9.08 | $2.80 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $103.33 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 1.3M |
| Earning Date | 01-08-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $837,323,000.00 | $132,357,000.00 |
| Revenue This Year | $7.57 | $17.63 |
| Revenue Next Year | $4.57 | $30.76 |
| P/E Ratio | ★ N/A | $29.50 |
| Revenue Growth | 0.98 | ★ 19.00 |
| 52 Week Low | $3.51 | $1.60 |
| 52 Week High | $23.20 | $3.43 |
| Indicator | TLRY | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 57.91 |
| Support Level | $8.61 | $2.50 |
| Resistance Level | $9.31 | $2.80 |
| Average True Range (ATR) | 0.56 | 0.09 |
| MACD | -0.26 | 0.00 |
| Stochastic Oscillator | 31.29 | 86.36 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.